Include home glucose readings if you use them, recent A1C results, kidney lab results if available, weight trend, symptoms, missed doses, diet changes, and all prescription or non-prescription products
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes
[2] [3] For many patients with established cardiovascular disease or high cardiovascular risk, SGLT2 inhibitors are preferred before GLP-1 receptor agonists where appropriate
Consideration of peptides for weight loss (e.g., CJC-1295, Ipamorelin) that encourage fat loss while preserving lean mass
Enough protein
But most people underestimate the one variable that determines whether that investment actually pays off: nutrition